arrow
A

Arndt Hartmann

university of erlangen nuremberg
H指数:97
被引数:4.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result Reporting

尿路上皮癌中的FGFR3检测:从患者识别到结果报告的最佳实践专家评论

2026-09-010
PRE
Cytokine-mediated activation of kidney-infiltrating CD8+ T cells enables their contribution to inflammation in human lupus nephritis

细胞因子介导的肾脏浸润CD8+ T细胞激活使其能够参与人类狼疮肾炎的炎症过程

2026-07-080
PRE
International Society of Urological Pathology Consensus Meeting 2024

国际泌尿病理学会共识会议2024

2025-12-010
PRE
Renal hemangioblastoma and renal cell carcinoma with fibromyomatous stroma and hemangioblastoma-like areas belong to the spectrum of one entity

肾血管母细胞瘤和伴有纤维肌瘤样间质及血管母细胞瘤样区域的肾细胞癌属于同一实体的谱系。

2025-11-030
PRE
Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial

非透明细胞肾细胞癌中,伊匹木单抗/纳武利尤单抗对比标准护理的 prospective randomized phase-II trial - SUNNIFORECAST trial 的结果

2025-04-010
OA
Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study

乳头状非肌层浸润性尿路上皮癌的混合三层分级系统的观察者间可重复性: 一项国际泌尿病理学研究

2025-03-010
OAAI
HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance

Hla-g表达与免疫逃避肌肉浸润性尿路上皮癌相关并驱动预后相关性

2024-10-140
OAAI